is mounjaro glp 1 agonist Tirzepatide (Mounjaro) GLP-1 receptor agonists like semaglutide
Description
The shedding often becomes noticeable two to four months after starting treatment or after significant weight loss, which is a key distinguishing feature
One particular retrospective study reported that the discontinuation of endoscopy occurred in less than 1% of procedures, yet was twice as common among GLP-1 RA users (Alkabbani et al

JCI Insight 5(2020)

Ongoing research efforts into this variant aim to uncover the molecular factors associated with its benefits, focusing on the analysis of transducer factor recruitment and receptor trafficking patterns in response to a range of clinical and non-clinical GLP-1RAs

However, in a preliminary study [11], metformin did not increase GLP-1 secretion from L cells in vitro
